Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study
Camões Neves J, Costa D, Cristiano M, Portela F, Fernandes AR, Fernandes S, Gonçalves N, Paulo JP, Portugal M, Gututui M, Fernandes D, Costa C, Madureira AM, Marques J, Conde PV, Damasceno J, Guimarães A, Rebelo A, Gonçalves M, Soares J, Mendes SS, Arroja B, Gonçalves R, Leal T; GEDII (Portuguese IBD Group)